Equities

N4 Pharma PLC

N4P:LSE

N4 Pharma PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)0.80
  • Today's Change0.00 / 0.00%
  • Shares traded18.36k
  • 1 Year change-56.76%
  • Beta-0.7727
Data delayed at least 20 minutes, as of May 17 2024 13:10 BST.
More ▼
DateOpenHighLowCloseVolume
Friday, May 17, 2024Fri, May 17, 20240.800.7720.750.8018,35818.36k
Thursday, May 16, 2024Thu, May 16, 20240.800.850.750.8014,53814.54k
Wednesday, May 15, 2024Wed, May 15, 20240.800.850.7720.80142,520142.52k
Tuesday, May 14, 2024Tue, May 14, 20240.800.850.750.8026,52726.53k
Monday, May 13, 2024Mon, May 13, 20240.800.850.750.8068,23368.23k
Friday, May 10, 2024Fri, May 10, 20240.800.7710.7710.8050,00050.00k
Thursday, May 09, 2024Thu, May 09, 20240.800.850.750.80371,490371.49k
Wednesday, May 08, 2024Wed, May 08, 20240.800.850.750.80107,621107.62k
Tuesday, May 07, 2024Tue, May 07, 20240.800.7980.750.8072,16272.16k
Friday, May 03, 2024Fri, May 03, 20240.800.7980.750.80198,696198.70k
Thursday, May 02, 2024Thu, May 02, 20240.800.850.8030.8024,00724.01k
Wednesday, May 01, 2024Wed, May 01, 20240.800.850.7570.80150,728150.73k
Tuesday, April 30, 2024Tue, Apr 30, 20240.800.750.750.806,6376.64k
Monday, April 29, 2024Mon, Apr 29, 20240.800.850.750.80644,688644.69k
Friday, April 26, 2024Fri, Apr 26, 20240.8250.850.750.775611,345611.35k
Thursday, April 25, 2024Thu, Apr 25, 20240.800.900.800.8253,285,0013.29m
Wednesday, April 24, 2024Wed, Apr 24, 20240.850.900.800.825823,510823.51k
Tuesday, April 23, 2024Tue, Apr 23, 20240.800.900.800.854,804,5584.80m
Monday, April 22, 2024Mon, Apr 22, 20240.800.920.800.85849,442849.44k
Data delayed at least 20 minutes, as of May 17 2024 14:10 BST.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.